Your browser doesn't support javascript.
loading
CCL22 signaling contributes to sorafenib resistance in hepatitis B virus-associated hepatocellular carcinoma.
Gao, Yanan; Fan, Xing; Li, Nan; Du, Chengzhi; Yang, Bin; Qin, Wenhao; Fu, Jing; Markowitz, Geoffrey J; Wang, Hongyang; Ma, Jianli; Cheng, Shuqun; Yang, Pengyuan.
Afiliação
  • Gao Y; CAS Key Laboratory of Infection and Immunity, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing, 100101, China.
  • Fan X; CAS Key Laboratory of Infection and Immunity, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing, 100101, China.
  • Li N; Department of Hepatic Surgery I, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, 200438, China.
  • Du C; CAS Key Laboratory of Infection and Immunity, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing, 100101, China.
  • Yang B; CAS Key Laboratory of Infection and Immunity, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing, 100101, China.
  • Qin W; National Center for Liver Cancer, Second Military Medical University, Shanghai, 200433, China.
  • Fu J; National Center for Liver Cancer, Second Military Medical University, Shanghai, 200433, China.
  • Markowitz GJ; Departments of Cardiothoracic Surgery and Cell and Developmental Biology, Neuberger Berman Lung Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Wang H; National Center for Liver Cancer, Second Military Medical University, Shanghai, 200433, China.
  • Ma J; Department of Pharmacy, General Hospital of the Chinese People's Liberation Army (PLAGH), 100048, Beijing, China. Electronic address: jianli.ma@163.com.
  • Cheng S; Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, 200433, China. Electronic address: chengshuqun@aliyun.com.
  • Yang P; CAS Key Laboratory of Infection and Immunity, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing, 100101, China. Electronic address: pyyang@ibp.ac.cn.
Pharmacol Res ; 157: 104800, 2020 07.
Article em En | MEDLINE | ID: mdl-32278046
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Linfócitos do Interstício Tumoral / Carcinoma Hepatocelular / Resistencia a Medicamentos Antineoplásicos / Inibidores de Proteínas Quinases / Quimiocina CCL22 / Sorafenibe / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Pharmacol Res Assunto da revista: FARMACOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Linfócitos do Interstício Tumoral / Carcinoma Hepatocelular / Resistencia a Medicamentos Antineoplásicos / Inibidores de Proteínas Quinases / Quimiocina CCL22 / Sorafenibe / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Pharmacol Res Assunto da revista: FARMACOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China